A bibliometric research based on hotspots and frontier trends of denosumab
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2022.929223
Abstract: Denosumab is a monoclonal antibody that targets and inhibits the osteoclast activating factor receptor activator for nuclear factor-κB ligand (RANKL). It has been widely used in the treatment of osteoporosis, giant cell tumors of bone,… read more here.
Keywords: research based; bibliometric research; frontier trends; hotspots frontier ... See more keywords